The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting

James G Ryall; Gordon S Lynch

Journal article

The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting

James G Ryall, Gordon S Lynch

Pharmacology and Therapeutics | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2008

DOI: 10.1016/j.pharmthera.2008.06.003

University of Melbourne Researchers

Gordon Lynch Author Anatomy and Neuroscience

James Ryall Author Anatomy and Neuroscience

Related Projects (3)

Targeting calcineurin for improving muscle regeneration in skeletal muscle disease

Muscular dystrophy is a term that covers a diverse group of inherited disorders characterised by progressive muscle weakness and wasting. Du..

Improving muscle regeneration in muscular dystrophy

Duchenne muscular dystrophy (DMD) is the most common and severe form of muscular dystrophy, caused by a lack of a protein called dystrophin...

Improving muscle function after injury

Muscles can be injured by excessive strains when playing sports, in road and workplace accidents, and during plastic and reconstructive surg..

Grants

Awarded by Australian Research Council

Awarded by National Health and Medical Research Council of Australia

Awarded by Muscular Dystrophy Association (USA)

Funding Acknowledgements

The funding for this research has been provided by generous grants from the Australian Research Council Discovery-Project funding scheme (DP0665071, DP0772781), the National Health and Medical Research Council of Australia (350439, 454561, 509313), the Muscular Dystrophy Association (USA, 3595,4167), Pfizer Inc. (USA), and Merck & Co. Inc. (USA).